Definium Therapeutics, Inc. (DFTX)
18.48
+0.68
(+3.85%)
USD |
NASDAQ |
Mar 25, 16:00
18.72
+0.24
(+1.33%)
After-Hours: 20:00
Definium Therapeutics Market Cap : 1.842B for March 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pulse Biosciences, Inc. | 1.478B |
| RxSight, Inc. | 271.53M |
| Plus Therapeutics, Inc. | 42.01M |
| Viridian Therapeutics, Inc. | 2.900B |
| Nutriband, Inc. | 46.19M |
Market Cap Related Metrics
| PEG Ratio | -1.048 |
| Price to Book Value | 5.543 |
| Price | 18.48 |
| Earnings Yield | -11.20% |
| PEGY Ratio | -1.048 |